INBS (Intelligent Bio Solutions Inc. Common Stock) Stock Analysis - Analyst Ratings
Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of May 21, 2026, INBS trades at $2.91 with a market cap of $8.73M and a P/E ratio of 0.34. INBS moved -11.85% today. Year to date, INBS is -74.27%; over the trailing twelve months it is -77.89%. Its 52-week range spans $2.27 to $27.50. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate INBS?
The average price target is $0.00.
INBS Key Metrics
Key financial metrics for INBS
Metric
Value
Price
$2.91
Market Cap
$8.73M
P/E Ratio
0.34
EPS
$8.95
Dividend Yield
0.00%
52-Week High
$27.50
52-Week Low
$2.27
Volume
169
Avg Volume
0
Revenue (TTM)
$3.91M
Net Income
$-11.65M
Gross Margin
47.25%
INBS Analyst Consensus
INBS analyst coverage data. Average price target: $0.00.